Activin; Alzheimer; prion; amino acid substitution screen; amyloid peptides; androgens (e.g. testosterone); anti-Müllerian hormone; DHEA; estrogens (e.g., estradiol); follicle-stimulating hormone (FSH); gamete; G protein-coupled membrane receptor, gonads; gonadotropin; GPR5; GPR54;high-affinity RFamide (Arg-Phe-NH2) peptide ligand; hypergonadotropic; hypoestrogenism; gonadotropins; luteinizing hormone (LH); hypoandrogenism; hypogonadism; idiopathic hypothalamic hypogonadism; impaired pubertal maturation; infertility; inhibin; KISS; Kiss1 gene; Kisspeptin; kisspeptins; Kiss1r; kisspeptin receptor; marker; metastasis-suppressor gene; metastatic melanomas; metastin; neuropeptides; testes; ovaries; ovulation; progesterone; receptor; sex hormones; spermatogenesis.
Becker JA, Mirjolet JF, Bernard J, Burgeon E, Simons MJ, Vassart G, Parmentier M, Libert F. Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors. Biochem Biophys Res Commun. 2005 Jan 21;326(3):677-86.
Canbay E, Ergen A, Bugra D, Yamaner S, Eraltan IY, Buyukuncu Y, Bulut T. Kisspeptin-54 levels are increased in patients with colorectal cancer. World J Surg. 2012 Sep;36(9):2218-24.
Canbay E, Ergen A, Bugra D, Yamaner S, Eraltan IY, Buyukuncu Y, Bulut T. Kisspeptin-54 levels are increased in patients with colorectal cancer. World J Surg. 2012 Sep;36(9):2218-24.
Cartwright JE, Williams PJ. Altered placental expression of kisspeptin and its receptor in pre-eclampsia. J Endocrinol. 2012 Jul;214(1):79-85.
Castaño JP, Martínez-Fuentes AJ, Gutiérrez-Pascual E, Vaudry H, Tena-Sempere M, Malagón MM. Intracellular signaling pathways activated by kisspeptins through GPR54: do multiple signals underlie function diversity? Peptides. 2009. Jan;30(1):10-5.
Chen Y, Yusenko MV, Kovacs G. Lack of KISS1R expression is associated with rapid progression of conventional renal cell carcinomas. J Pathol. 2011 Jan;223(1):46-53. doi: 10.1002/path.2764.
Cho SG, Li D, Stafford LJ, Luo J, Rodriguez-Villanueva M, Wang Y, Liu M. KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J Cell Biochem. 2009 Aug 15; 107(6):1139-49.
Cho SG, Wang Y, Rodriguez M, Tan K, Zhang W, Luo J, Li D, Liu M. Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cancer Res. 2011 Oct 15;71(20):6535-46.
Cho SG, Yi Z, Pang X, Yi T, Wang Y, Luo J, Wu Z, Li D, Liu M. Kisspeptin-10, a KISS1-derived decapeptide, inhibits tumor angiogenesis by suppressing Sp1-mediated VEGF expression and FAK/Rho GTPase activation. Cancer Res. 2009 Sep
Curtis AE, Murphy KG, Chaudhri OB, Ramachandran R, Young AM, Waxman J, Nijher GM, Bewick GA, Ghatei MA, Bloom SR, Dhillo WS. Kisspeptin is released from human prostate cancer cell lines but plasma kisspeptin is not elevated in patients with prostate cancer. Oncol Rep. 2010 Jun;23(6):1729-34.
Dhillo WS, Savage P, Murphy KG, Chaudhri OB, Patterson M, Nijher GM, Foggo VM, Dancey GS, Mitchell H, Seckl MJ, Ghatei MA, Bloom SR. Plasma kisspeptin is raised in patients with gestational trophoblastic neoplasia and falls during treatment. Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E878-84.
Ergen A, Canbay E, Bugra D, Zeybek U, Yamaner S, Bulut T. Plasma Kisspeptin-54 levels in gastric cancer patients. Int J Surg. 2012 Sep 5. pii: S1743-9191(12)00763-7.
Gottsch ML, Clifton DK, Steiner RA. From KISS1 to kisspeptins: An historical perspective and suggested nomenclature. Peptides. 2009 Jan;30(1):4-9.
Gutiérrez-Pascual E, Leprince J, Martínez-Fuentes AJ, Ségalas-Milazzo I, Pineda R, Roa J, Duran-Prado M, Guilhaudis L, Desperrois E, Lebreton A, Pinilla L, Tonon MC, Malagón MM, Vaudry H, Tena-Sempere M, Castaño JP. In vivo and in vitro structure-activity relationships and structural conformation of Kisspeptin-10-related peptides. Mol Pharmacol. 2009 Jul;76(1):58-67.
Harms JF, Welch DR, Miele ME. KISS1 metastasis suppression and emergent pathways. Clin Exp Metastasis. 2003;20(1):11-8. Review. PubMed PMID: 12650602.
Hiden U, Bilban M, Knöfler M, Desoye G. Kisspeptins and the placenta: regulation of trophoblast invasion. Rev Endocr Metab Disord. 2007 Mar;8(1):31-9.
Jayasena CN, Comninos AN, Januszewski A, Gabra H, Taylor A, Harvey RA, Ghatei MA, Bloom SR, Dhillo WS. Plasma kisspeptin: a potential biomarker of tumormetastasis in patients with ovarian carcinoma. Clin Chem. 2012 Jun;58(6):1061-3.
Jayasena CN, Nijher GM, Comninos AN, Abbara A, Januszewki A, Vaal ML, Sriskandarajah L, Murphy KG, Farzad Z, Ghatei MA, Bloom SR, Dhillo WS. The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab. 2011 Dec;96(12):E1963-72.
Kang HS, Baba T, Mandai M, Matsumura N, Hamanishi J, Kharma B, Kondoh E, Yoshioka Y, Oishi S, Fujii N, Murphy SK, Konishi I. GPR54 is a target for suppression of metastasis in endometrial cancer. Mol Cancer Ther. 2011. Apr;10(4):580-90.
Kirby HR, Maguire JJ, Colledge WH, Davenport AP. International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function. Pharmacol Rev. 2010 Dec;62(4):565-78.
Kotani M, Detheux M, Vandenbogaerde A, Communi D, Vanderwinden JM, Le Poul E, Brézillon S, Tyldesley R, Suarez-Huerta N, Vandeput F, Blanpain C, Schiffmann SN, Vassart G, Parmentier M. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001 Sep 14;276(37):34631-6.
Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst. 1996 Dec 4;88(23):1731-7.
Lee YR, Tsunekawa K, Moon MJ, Um HN, Hwang JI, Osugi T, Otaki N, Sunakawa Y, Kim K, Vaudry H, Kwon HB, Seong JY, Tsutsui K. Molecular evolution of multiple forms of kisspeptins and GPR54 receptors in vertebrates. Endocrinology. 2009 Jun;150(6):2837-46.
Makri A, Pissimissis N, Lembessis P, Polychronakos C, Koutsilieris M. The kisspeptin (KiSS-1)/GPR54 system in cancer biology. Cancer Treat Rev. 2008 Dec;34(8):682-92. Epub 2008 Jun 25.
Martínez-Fuentes AJ, Molina M, Vázquez-Martínez R, Gahete MD, Jiménez-Reina L, Moreno-Fernández J, Benito-López P, Quintero A, de la Riva A, Diéguez C, Soto A, Leal-Cerro A, Resmini E, Webb SM, Zatelli MC, degli Uberti EC, Malagón MM, Luque RM, Castaño JP. Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10. Eur J Endocrinol. 2011 Mar;164(3):355-62.
Meczekalski B, Podfigurna-Stopa A, Genazzani AR. Why kisspeptin is such important for reproduction? Gynecol Endocrinol. 2011 Jan;27(1):8-13.
Milton NG, Chilumuri A, Rocha-Ferreira E, Nercessian AN, Ashioti M. Kisspeptin Prevention of Amyloid-β Peptide Neurotoxicity in Vitro. ACS Chem Neurosci. 2012 Sep 19;3(9):706-19.
Milton NG. In Vitro Activities of Kissorphin, a Novel Hexapeptide KiSS-1 Derivative, in Neuronal Cells. J Amino Acids. 2012;2012:691463.
Murphy KG. Kisspeptins: regulators of metastasis and the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol. 2005 Aug;17(8):519-25.
Murphy KG. Kisspeptins: regulators of metastasis and the hypothalamic-pituitary-gonadal axis. J Neuroendocrinol. 2005 Aug;17(8):519-25. Navenot JM, Fujii N, Peiper SC. Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis. Mol Pharmacol. 2009 Jun;75 (6):1300-6.
Navenot JM, Fujii N, Peiper SC. KiSS1 metastasis suppressor gene product induces suppression of tyrosine kinase receptor signaling to Akt, tumor necrosis factor family ligand expression, and apoptosis. Mol Pharmacol. 2009 May;75(5):1074-83.
Navenot JM, Wang Z, Chopin M, Fujii N, Peiper SC. Kisspeptin-10-induced signaling of GPR54 negatively regulates chemotactic responses mediated by CXCR4: a potential mechanism for the metastasis suppressor activity of kisspeptins. Cancer Res. 2005 Nov 15;65(22):10450-6.
Oakley AE, Clifton DK, Steiner RA. Kisspeptin signaling in the brain. Endocr Rev. 2009 Oct;30(6):713-43.
Orsini MJ, Klein MA, Beavers MP, Connolly PJ, Middleton SA, Mayo KH.; Metastin (KiSS-1) mimetics identified from peptide structure-activity relationship-derived pharmacophores and directed small molecule database screening. J Med Chem. 2007 Feb 8;50(3):462-71. Ozcan M, Alcin E, Ayar A, Yilmaz B, Sandal S, Kelestimur H. Kisspeptin-10 elicits triphasic cytosolic calcium responses in immortalized GT1-7 GnRH neurones. Neurosci Lett. 2011 Mar 29;492(1):55-8.
Pampillo M, Babwah AV. Assessment of constitutive activity and internalization of GPR54 (KISS1-R). Methods Enzymol. 2010;484:75-93.
Pampillo M, Camuso N, Taylor JE, Szereszewski JM, Ahow MR, Zajac M, Millar RP,Bhattacharya M, Babwah AV. Regulation of GPR54 signaling by GRK2 and{beta}-arrestin. Mol Endocrinol. 2009 Dec;23(12):2060-74.
Patterson M, Murphy KG, Thompson EL, Patel S, Ghatei MA, Bloom SR. Administration of kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma luteinising hormone and testosterone in male adult rats. J Neuroendocrinol. 2006 May;18(5):349-54.
Peilecka-Fortuna et al. (2007) Kisspeptin acts directly and indirectly to increase GnRH neuron activity and its effects are modulated by estradiol. Endocrinology 149 1979.
Poomthavorn P, Wong SH, Higgins S, Werther GA, Russo VC. Activation of a prometastatic gene expression program in hypoxic neuroblastoma cells. Endocr Relat Cancer. 2009 Sep;16(3):991-1004. Epub 2009 May 7. PubMed PMID: 19423615.
Qureshi IZ, Kanwal S. Novel role of puberty onset protein kisspeptin as an anticoagulation peptide. Blood Coagul Fibrinolysis. 2011 Jan;22(1):40-9.
Ramaesh T, Logie JJ, Roseweir AK, Millar RP, Walker BR, Hadoke PW, ReynoldsRM. Kisspeptin-10 inhibits angiogenesis in human placental vessels ex vivo and endothelial cells in vitro. Endocrinology. 2010 Dec;151(12):5927-34.
Reynolds RM, Logie JJ, Roseweir AK, McKnight AJ, Millar RP. A role for kisspeptins in pregnancy: facts and speculations. Reproduction. 2009 Jul;138(1):1-7.
Roseweir AK, Katz AA, Millar RP. Kisspeptin-10 inhibits cell migration in vitro via a receptor-GSK3 beta-FAK feedback loop in HTR8SVneo cells. Placenta. 2012 May;33(5):408-15.
Ruiz MT, Galbiatti AL, Pavarino EC, Maniglia JV, Goloni-Bertollo EM. Q36R polymorphism of KiSS-1 gene in Brazilian head and neck cancer patients. Mol Biol Rep. 2012 May;39(5):6029-34.
Sawyer I, Smillie SJ, Bodkin JV, Fernandes E, O'Byrne KT, Brain SD. The vasoactive potential of kisspeptin-10 in the peripheral vasculature. PLoS One. 2011 Feb 9;6(2):e14671.
Seminara SB. Kisspeptin in reproduction. Semin Reprod Med. 2007. Sep;25(5):337-43.
Shin R, Welch DR, Mishra VK, Nash KT, Hurst DR, Rama Krishna N. Nuclear magnetic resonance and circular dichroism study of metastin (Kisspeptin-54) structure in solution. Clin Exp Metastasis. 2009;26(6):527-33.
Shoji I, Hirose T, Mori N, Hiraishi K, Kato I, Shibasaki A, Yamamoto H, Ohba K, Kaneko K, Morimoto R, Satoh F, Kohzuki M, Totsune K, Takahashi K. Expression of kisspeptins and kisspeptin receptor in the kidney of chronic renal failure rats. Peptides. 2010 Oct;31(10):1920-5.
Styne DM, Grumbach MM. Puberty: Ontogeny, neuroendocrinology, physiology, and disorders. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 12th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 25.
Tanaka M, Csabafi K, Telegdy G. Neurotransmissions of antidepressant-like effects of kisspeptin-13. Regul Pept. 2012 Sep 18. pii: S0167-0115(12)00233-9. doi: 10.1016/j.regpep.2012.08.017.
Tena-Sempere M, Felip A, Gómez A, Zanuy S, Carrillo M. Comparative insights of the kisspeptin/kisspeptin receptor system: lessons from non-mammalian vertebrates. Gen Comp Endocrinol. 2012 Jan 15;175(2):234-43.
Tena-Sempere M. GPR54 and kisspeptin in reproduction. Hum Reprod Update. 2006 Sep-Oct;12(5):631-9.
Tena-Sempere M. The roles of kisspeptins and G protein-coupled receptor-54 inpubertal development. Curr Opin Pediatr. 2006 Aug;18(4):442-7.
Tomita K, Niida A, Oishi S, Ohno H, Cluzeau J, Navenot JM, Wang ZX, Peiper SC, Fujii N. Structure-activity relationship study on small peptidic GPR54 agonists. Bioorg Med Chem. 2006 Nov 15;14(22):7595-603.
Tomita K, Oishi S, Ohno H, Fujii N. Structure-activity relationship study and NMR analysis of fluorobenzoyl pentapeptide GPR54 agonists. Biopolymers. 2008;90(4):503-11.
Tomita K, Oishi S, Ohno H, Peiper SC, Fujii N. Development of novel G-protein-coupled receptor 54 agonists with resistance to degradation by matrix metalloproteinase. J Med Chem. 2008 Dec 11;51(23):7645-9.
Zajac M, Law J, Cvetkovic DD, Pampillo M, McColl L, Pape C, Di Guglielmo GM, Postovit LM, Babwah AV, Bhattacharya M. GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness. PLoS One. 2011;6(6):e21599.